Skip to content

Orphan Drugs: FDA PDUFA Dates February – March 2014

February 17, 2014

.

.

.

.

Investors and traders will be watching several orphan drug FDA PDUFA dates in February – March 2014.

FDA PDUFA Dates February – March 2014

Generic       Name Trade          Name Sponsor Indication 2014          PDUFA  Date
Droxidopa   * Northera Chelsea   Therapeutics Symptomatic     Neurogenic Orthostatic Hypotension For Patients With Primary Autonomic     Failure 02/18
Metreleptin   ** Bristol-Myers   Squibb/AstraZeneca Lipodystrophy 02/27
Miltefosine   *** Impavido Paladin   Labs Leishmaniasis 03/19
Ivacaftor **** Kalydeco Vertex   Pharmaceuticals Cystic   Fibrosis, ages 6 & older who have non-G551D gating mutations 03/27

* Resubmitted NDA   ** Priority Review   *** NDA    **** sNDA, Priority Review

.

Please note the links for the following 2 chart columns above :

1) “Generic Name” Column Link = Is a source for the FDA PDUFA Date

2) “Indication” Column Link = Is the FDA Orphan Drug Product Designation Database Link.

Please notify at orphandruganaut@gmail.com if any updates or corrections are available.

Please Note: “Azt” by John Crawford (Photographer) [Public domain] | Wikimedia Commons.

Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: